SL65.0155

From Wikipedia, the free encyclopedia
SL65.0155
Systematic (IUPAC) name
5-(5-amino-6-chloro-2,3-dihydro-1,4-benzodioxin-8-yl)-3-(1-phenethyl-4-piperidyl)-1,3,4-oxadiazol-2-one hydrochloride
Clinical data
Legal status ?
Identifiers
CAS number ?
ATC code None
PubChem CID 9805718
ChemSpider 7981478
Chemical data
Formula C23H26Cl2N4O4 
Mol. mass 493.38 g/mol

SL65.0155 is a selective 5-HT4 receptor partial agonist (Ki = 0.6 nM; IA = 40-50% (relative to 5-HT)).[1] It potently enhances cognition, learning, and memory,[1][2][3][4][5][6] and also possesses antidepressant effects.[7] SL65.0155 was in phase II clinical trials around 2004-2006 for the treatment of memory deficits and dementia but no new information has surfaced since and it appears to have been abandoned.[8][9]

See also

References

  1. ↑ 1.0 1.1 Moser PC, Bergis OE, Jegham S, et al. (August 2002). "SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties". The Journal of Pharmacology and Experimental Therapeutics 302 (2): 731–41. doi:10.1124/jpet.102.034249. PMID 12130738. 
  2. ↑ Spencer JP, Brown JT, Richardson JC, et al. (2004). "Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease". Neuroscience 129 (1): 49–54. doi:10.1016/j.neuroscience.2004.06.070. PMID 15489027. 
  3. ↑ Micale V, Leggio GM, Mazzola C, Drago F (November 2006). "Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia". Brain Research 1121 (1): 207–15. doi:10.1016/j.brainres.2006.08.108. PMID 17011531. 
  4. ↑ Restivo L, Roman F, Dumuis A, Bockaert J, Marchetti E, Ammassari-Teule M (September 2008). "The promnesic effect of G-protein-coupled 5-HT4 receptors activation is mediated by a potentiation of learning-induced spine growth in the mouse hippocampus". Neuropsychopharmacology 33 (10): 2427–34. doi:10.1038/sj.npp.1301644. PMID 18075492. 
  5. ↑ Marchetti E, Jacquet M, Jeltsch H, et al. (July 2008). "Complete recovery of olfactory associative learning by activation of 5-HT4 receptors after dentate granule cell damage in rats". Neurobiology of Learning and Memory 90 (1): 185–91. doi:10.1016/j.nlm.2008.03.010. PMID 18485752. 
  6. ↑ Hille C, Bate S, Davis J, Gonzalez MI (December 2008). "5-HT4 receptor agonism in the five-choice serial reaction time task". Behavioural Brain Research 195 (1): 180–6. doi:10.1016/j.bbr.2008.08.007. PMID 18765258. 
  7. ↑ Tamburella A, Micale V, Navarria A, Drago F (October 2009). "Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats". Progress in Neuro-psychopharmacology & Biological Psychiatry 33 (7): 1205–10. doi:10.1016/j.pnpbp.2009.07.001. PMID 19596038. 
  8. ↑ Bockaert J, Claeysen S, Compan V, Dumuis A (February 2004). "5-HT4 receptors". Current Drug Targets. CNS and Neurological Disorders 3 (1): 39–51. PMID 14965243. 
  9. ↑ Roth, Bryan L. (2006). The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics (The Receptors). Totowa, NJ: Humana Press. ISBN 1-58829-568-0. 
Psychoanaleptics: Antidementia agents (N06D)
Anticholinesterases
Others

M: PSO/PSI

mepr

dsrd (o, p, m, p, a, d, s), sysi/epon, spvo

proc (eval/thrp), drug (N5A/5B/5C/6A/6B/6D)

Nootropics (N06B)
Acetylcholinesterases
Adenosine antagonists
Ampakines
Ampakine-like
D1 Agonists
Eugeroics
GABAA α5 Inverse Agonists
H3 Antagonists
mACh Agonists
nACh Agonists
NMDA agonists
NMDA antagonists
Racetams
Neurogenics
Others


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.